149 related articles for article (PubMed ID: 14654789)
21. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
22. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
23. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
Li J; Zhang X; Sejas DP; Pang Q
Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
[TBL] [Abstract][Full Text] [Related]
24. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
[TBL] [Abstract][Full Text] [Related]
25. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
26. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
27. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis.
Park K; Kim K; Rho SB; Choi K; Kim D; Oh SH; Park J; Lee SH; Lee JH
Cancer Res; 2005 Feb; 65(3):749-57. PubMed ID: 15705871
[TBL] [Abstract][Full Text] [Related]
28. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
29. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
30. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest.
Yun J; Zhong Q; Kwak JY; Lee WH
Oncogene; 2005 Jun; 24(25):4009-16. PubMed ID: 15782115
[TBL] [Abstract][Full Text] [Related]
31. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
32. IFI16 and NM23 bind to a common DNA fragment both in the P53 and the cMYC gene promoters.
Egistelli L; Chichiarelli S; Gaucci E; Eufemi M; Schininà ME; Giorgi A; Lascu I; Turano C; Giartosio A; Cervoni L
J Cell Biochem; 2009 Mar; 106(4):666-72. PubMed ID: 19170058
[TBL] [Abstract][Full Text] [Related]
33. Thermodynamics and stability of the PAAD/DAPIN/PYRIN domain of IFI-16.
Dalal K; Pio F
FEBS Lett; 2006 May; 580(13):3083-90. PubMed ID: 16678172
[TBL] [Abstract][Full Text] [Related]
34. Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation.
Semont A; Nowak EB; Silva Lages C; Mathieu C; Mouthon MA; May E; Allemand I; Millet P; Boussin FD
Oncogene; 2004 Nov; 23(52):8497-508. PubMed ID: 15361846
[TBL] [Abstract][Full Text] [Related]
35. IFI16 as a negative regulator in the regulation of p53 and p21(Waf1).
Kwak JC; Ongusaha PP; Ouchi T; Lee SW
J Biol Chem; 2003 Oct; 278(42):40899-904. PubMed ID: 12925527
[TBL] [Abstract][Full Text] [Related]
36. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
Hohenstein P; Kielman MF; Breukel C; Bennett LM; Wiseman R; Krimpenfort P; Cornelisse C; van Ommen GJ; Devilee P; Fodde R
Oncogene; 2001 May; 20(20):2544-50. PubMed ID: 11420664
[TBL] [Abstract][Full Text] [Related]
37. Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation.
Shi XL; Yang J; Mao N; Wu JH; Ren LF; Yang Y; Yin XL; Wei L; Li MY; Wang BN
Acta Pharmacol Sin; 2015 Feb; 36(2):252-8. PubMed ID: 25544361
[TBL] [Abstract][Full Text] [Related]
38. IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases.
Choubey D; Panchanathan R
Ageing Res Rev; 2016 Jul; 28():27-36. PubMed ID: 27063514
[TBL] [Abstract][Full Text] [Related]
39. Loss of p53-regulatory protein IFI16 induces NBS1 leading to activation of p53-mediated checkpoint by phosphorylation of p53 SER37.
Tawara H; Fujiuchi N; Sironi J; Martin S; Aglipay J; Ouchi M; Taga M; Chen PL; Ouchi T
Front Biosci; 2008 Jan; 13():240-8. PubMed ID: 17981542
[TBL] [Abstract][Full Text] [Related]
40. IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome.
Lin W; Zhao Z; Ni Z; Zhao Y; Du W; Chen S
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
